Combination of Castle Biosciences’ DecisionDx-UM and PRAME show predicting outcomes in patients with uveal melanoma: Study: Friendswood, Texas Friday, December 19, 2025, 15:00 H ...
FRIENDSWOOD, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CSTL), a company improving health through innovative tests ...
York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...
The Vietnam Academy of Science and Technology (VAST) organised a ceremony in Hanoi on December 11 to announce DNA ...
CAGR is driven by advancements in epigenetics research, methylation analysis technologies, and the rising need for ...
A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads” recently published in ...
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...
The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Comparing proteomics to genomics reveals essential insights into their contributions to systems biology and experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback